Post-Acute Sequelae of COVID-19 and Polypharmacy: If You Think There’s Too Much Polypharmacy Now, Just Wait

Authors

Demetra Antimisiaris, University of LouisvilleFollow

Funder

The author(s) received no specific funding for this work (Thanks to UL ID for collaborating with us!)

Abstract

The intersection of increased chronic disease burden worldwide with the COVID-19 pandemic was called the “perfect storm”. This article discusses yet another perfect storm: Post COVID-19 (acute and non-acute) syndrome, high chronic disease burdens, advanced age, and polypharmacy. The expected hyper polypharmacy that should result from the added disease and symptom burden due to post COVID-19 syndrome is discussed, as well as the importance of studying the incidence and characteristics to be able to address avoidable medication-related problems.

DOI

10.18297/jri/vol5/iss1/19

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

Recommended Citation

Antimisiaris, Demetra (2021) "Post-Acute Sequelae of COVID-19 and Polypharmacy: If You Think There’s Too Much Polypharmacy Now, Just Wait," The University of Louisville Journal of Respiratory Infections: Vol. 5 : Iss. 1 , Article 19.
DOI: https://doi.org/10.18297/jri/vol5/iss1/19
Available at: https://ir.library.louisville.edu/jri/vol5/iss1/19